Ameritas Investment Partners’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-856
| Closed | -$9.21K | – | 3281 |
|
|
2025
Q1 | $9.21K | Hold |
856
| – | – | ﹤0.01% | 2848 |
|
|
2024
Q4 | $11K | Hold |
856
| – | – | ﹤0.01% | 2877 |
|
|
2024
Q3 | $23.6K | Hold |
856
| – | – | ﹤0.01% | 2563 |
|
|
2024
Q2 | $24.8K | Hold |
856
| – | – | ﹤0.01% | 2525 |
|
|
2024
Q1 | $38.2K | Hold |
856
| – | – | ﹤0.01% | 2289 |
|
|
2023
Q4 | $33.2K | Hold |
856
| – | – | ﹤0.01% | 2358 |
|
|
2023
Q3 | $25.2K | Buy |
856
+207
| +32% | +$6.08K | ﹤0.01% | 2434 |
|
|
2023
Q2 | $41.3K | Hold |
649
| – | – | ﹤0.01% | 2157 |
|
|
2023
Q1 | $30.6K | Hold |
649
| – | – | ﹤0.01% | 2253 |
|
|
2022
Q4 | $38.7K | Hold |
649
| – | – | ﹤0.01% | 2234 |
|
|
2022
Q3 | $95K | Hold |
649
| – | – | ﹤0.01% | 1524 |
|
|
2022
Q2 | $84K | Buy |
649
+74
| +13% | +$9.58K | ﹤0.01% | 1639 |
|
|
2022
Q1 | $58K | Buy |
575
+484
| +532% | +$48.8K | ﹤0.01% | 1975 |
|
|
2021
Q4 | $14K | Hold |
91
| – | – | ﹤0.01% | 2789 |
|
|
2021
Q3 | $27K | Buy |
+91
| New | +$27K | ﹤0.01% | 2535 |
|